Human antigen-specific IgA responses in blood and secondary lymphoid tissue: an analysis of help and suppression.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 6198382)

Published in J Immunol on March 01, 1984

Authors

G W McCaughan, E Adams, A Basten

Articles by these authors

A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47

A receptor for antibody on B lymphocytes. II. Immunochemical and electron microscopy characteristics. J Exp Med (1972) 4.63

Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55

Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med (1970) 4.34

Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature (1991) 4.04

Induction of self-tolerance in mature peripheral B lymphocytes. Nature (1989) 4.02

Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut (1998) 3.77

Mechanism of eosinophilia. I. Factors affecting the eosinophil response of rats to Trichinella spiralis. J Exp Med (1970) 3.40

Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut (1999) 3.36

Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell (1993) 3.09

T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06

Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03

Metabolism of proline and the hydroxyprolines. Annu Rev Biochem (1980) 2.91

Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77

Cell interactions in the immune response in vitro. IV. Comparison of the effects of antigen-specific and allogeneic thymus-derived cell factors. J Exp Med (1972) 2.48

Mycobacterium leprae antigens involved in human immune responses. I. Identification of four antigens by monoclonal antibodies. J Immunol (1985) 2.40

Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection. J Gastroenterol Hepatol (2007) 2.35

Mapping quantitative trait loci for murine growth: a closer look at genetic architecture. Genet Res (1999) 2.27

Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15

Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol (1999) 2.12

Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology (1996) 2.01

Terlipressin therapy for moderate-to-severe hyponatraemia in patients with liver failure. Intern Med J (2013) 2.00

Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science (1991) 1.97

The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med (1996) 1.96

Cell interactions in the immune response in vitro. 3. Specific collaboration across a cell impermeable membrane. J Exp Med (1972) 1.96

Circulating T and B lymphocytes of the mouse. II. Lifespan. Cell Immunol (1973) 1.94

Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus. BMJ (1997) 1.92

Receptor for antibody-antigen complexes used to separate T cells from B cells. Nat New Biol (1972) 1.87

Breakdown of self-tolerance in anergic B lymphocytes. Nature (1991) 1.87

Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. Immunol Cell Biol (2001) 1.85

Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology (1999) 1.84

Immunoreactivity of a 70 kD protein purified from Mycobacterium bovis Bacillus Calmette-Guerin by monoclonal antibody affinity chromatography. J Exp Med (1986) 1.78

Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol Rev (1996) 1.77

Homology of the 70-kilodalton antigens from Mycobacterium leprae and Mycobacterium bovis with the Mycobacterium tuberculosis 71-kilodalton antigen and with the conserved heat shock protein 70 of eucaryotes. Infect Immun (1989) 1.75

Mechanisms for eosinophilic and neutrophilic leucocytoses. Br Med J (1971) 1.66

High-dose/activation-associated tolerance: a mechanism for allograft tolerance. Transplantation (1997) 1.65

Reproduction of radiologic images on plain paper. Radiographics (1998) 1.65

A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation (2001) 1.61

Relationship between Fc receptors, antigen-binding sites on T and B cells, and H-2 complex-associated determinants. J Exp Med (1975) 1.58

Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells. Gastroenterology (2000) 1.55

Cutting edge: anti-CD154 therapeutic antibodies induce infectious transplantation tolerance. J Immunol (2000) 1.55

CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scand J Immunol (2001) 1.53

Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab (2001) 1.52

Specific collaboration between T and B lymphocytes across a cell impermeable membrane in vitro. Nat New Biol (1972) 1.49

Mechanism of eosinophilia. 3. Suppression of eosinophilia by agents known to modify immune responses. Blood (1970) 1.48

Specificity of cell-mediated cytotoxicity against human melanoma lines: evidence for "non-specific" killing by activated T-cells. Int J Cancer (1975) 1.48

Antigen-specific primary activation of CD8+ T cells within the liver. J Immunol (2001) 1.47

Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med (1971) 1.46

Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival. Blood (2001) 1.45

Multiple endoscopies in a Sydney blood donor found positive for hepatitis B and C antibodies. Med J Aust (1996) 1.40

The role of CD4+ T-cell subsets in determining transplantation rejection or tolerance. Immunol Rev (2001) 1.40

Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. Blood (2001) 1.37

A subpopulation of T cells bearing Fc receptors. J Immunol (1975) 1.35

Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J Exp Med (1992) 1.33

Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8. Eur J Biochem (2000) 1.32

Sequence and immunogenicity of the 70-kDa heat shock protein of Mycobacterium leprae. J Immunol (1991) 1.31

Coenzyme content of purified alanine racemase from Pseudomonas. Biochem Biophys Res Commun (1969) 1.30

Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells. J Immunol (1998) 1.26

Humoral and cell mediated responses in vitro of spleen cells from mice with thymic aplasia (nude mice). Aust J Exp Biol Med Sci (1972) 1.26

Multicentre collaboration in 162 tissue-typed renal transplants. The London and Regional Transplant Group, March, 1969, to December, 1970. Lancet (1971) 1.25

Characterization of the human homolog of the rat MRC OX-2 membrane glycoprotein. Immunogenetics (1987) 1.24

The characterization and immunoreactivity of a 70 kD protein common to Mycobacterium leprae and Mycobacterium bovis (BCG). Lepr Rev (1986) 1.24

Long-term survival with tumor regression in androgen-induced liver tumors. Cancer (1985) 1.23

Metabolism of proline and of hydroxyproline. Int Rev Connect Tissue Res (1970) 1.23

Lymphomas in E mu-Pim1 transgenic mice exposed to pulsed 900 MHZ electromagnetic fields. Radiat Res (1997) 1.23

Self tolerance in the B-cell repertoire. Immunol Rev (1991) 1.22

Immune function in aged mice. II. B-cell function. Cell Immunol (1977) 1.20

Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology (1996) 1.19

Analysis of purity in 19 drug product tablets containing clopidogrel: 18 copies versus the original brand. J Pharm Biomed Anal (2004) 1.19

D-lysine catabolic pathway in Pseudomonas putida: interrelations with L-lysine catabolism. J Bacteriol (1974) 1.19

HLA family studies and multiple sclerosis: A common gene, dominantly expressed. Hum Immunol (1981) 1.19

False detection of negative-strand hepatitis C virus RNA. Lancet (1994) 1.18

The gene for MRC OX-2 membrane glycoprotein is localized on human chromosome 3. Immunogenetics (1987) 1.18

Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut (2000) 1.18

Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells. Int J Cancer (1975) 1.18

Intrinsic B-cell hyporesponsiveness accounts for self-tolerance in lysozyme/anti-lysozyme double-transgenic mice. Proc Natl Acad Sci U S A (1990) 1.17

Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids. Infect Immun (1989) 1.16

B cell life span: a review. Immunol Cell Biol (1997) 1.15

The impact of illness and the impact of school closure on social contact patterns. Health Technol Assess (2010) 1.15

Suppressor cells in humoral immunity and tolerance. Br Med Bull (1976) 1.14

Influences on the lifespan of B cell subpopulations defined by different phenotypes. Eur J Immunol (1997) 1.14

Suppressor T cell memory. II. The role of memory suppressor T cells in tolerance to human gamma globulin. J Exp Med (1983) 1.14

Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepat (1997) 1.14

Outer periarteriolar lymphoid sheath arrest and subsequent differentiation of both naive and tolerant immunoglobulin transgenic B cells is determined by B cell receptor occupancy. J Exp Med (1997) 1.13

Cell interactions in the immune response in vitro. I. Metabolic activities of T cells in a collaborative antibody response. Eur J Immunol (1972) 1.13

B cell activation, tolerance and antigen-presenting function. Curr Opin Immunol (1995) 1.12

The need for central and peripheral tolerance in the B cell repertoire. Science (1990) 1.12

Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. Proc Natl Acad Sci U S A (1994) 1.11

Immune function in aged mice. I. T-cell responsiveness using phytohaemagglutinin as a functional probe. Cell Immunol (1977) 1.10

Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression. Gut (2001) 1.10

Suppressor T-cell memory. Nature (1978) 1.10

Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme. Proc Natl Acad Sci U S A (1991) 1.09

Inflammatory pseudotumor of the liver causing biliary obstruction. Treatment by biliary stenting with 5-year follow-up. J Clin Gastroenterol (1991) 1.09

Immune complexes in thrombocytopenic patients: cause or effect? Br J Haematol (1980) 1.09

Two highly conserved glutamic acid residues in the predicted beta propeller domain of dipeptidyl peptidase IV are required for its enzyme activity. FEBS Lett (1999) 1.09

Immune function in aged mice. IV. Loss of T cell and B cell function in thymus-dependent antibody responses. Eur J Immunol (1978) 1.09

Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection. Transplantation (1993) 1.08